Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

• Status: Completed
• Trial end date: 2017-06-01

Summary

This study will assess the safety , efficacy and pharmacokinetics of ceftazidime avibactam and metronidazole versus meropenem in paediatric population (from 3 months to less than 18 years of age )with complicated intra-abdominal infections (cIAIs)

• Phase: Phase 2

Details

• Lead Sponsor: AstraZeneca; Pfizer
• Collaborator: PRA Health Sciences
• Treatments: Avibactam; Avibactam, ceftazidime drug combination; Ceftazidime; Meropenem; Metronidazole; Thienamycins